Clinical Trial Update: One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients

View source ↗

Summary

A completed one-year prospective observational study evaluating BMI changes associated with a 5-alpha reductase inhibitor in Korean patients with benign prostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Benign Prostatic Hyperplasia | Status: COMPLETED